Medical information Clinical review pending

Genetic Testing

ALPL Gene Odontohypophosphatasia Genetic Test

The ALPL Gene Odontohypophosphatasia Genetic Test analyzes the ALPL gene to identify mutations linked to odontohypophosphatasia, a rare metabolic disorder affecting bone and dental health. This test uses Next Generation Sequencing (NGS) for precise detection of genetic variations.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Blood sample (usually collected in an EDTA tube) or saliva sample. Confirm specific requirements with the laboratory before booking.
Results: Results are typically available within 3 to 4 weeks. Confirm the exact turnaround time with the laboratory before booking.
Preparation: No specific fasting is required. Discuss any medications you are taking with your doctor or the laboratory. A genetic counseling session and family history assessment are recommended before the test.

Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the ALPL Gene Odontohypophosphatasia Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Individuals with symptoms suggestive of odontohypophosphatasia (e.g., premature loss of baby teeth, dental abnormalities, bone pain, fractures).
✓Family history of odontohypophosphatasia or related metabolic bone disorders.
✓Individuals seeking genetic counseling regarding risks associated with ALPL gene mutations.
✓Confirmation of diagnosis in suspected cases.
✓Prenatal diagnosis for families with a known history of the condition (requires specialist consultation).

In plain language

What this test helps you understand

This test helps identify specific mutations in the ALPL gene associated with odontohypophosphatasia and related metabolic bone diseases. It aids in confirming a diagnosis, understanding the genetic basis of the condition, and informing family members about potential risks.

The ALPL Gene Odontohypophosphatasia NGS Genetic DNA Test is a specialized diagnostic tool used to identify mutations in the ALPL gene. This gene provides instructions for making an enzyme essential for bone and tooth development and mineralization. Mutations in this gene can lead to odontohypophosphatasia, a rare metabolic disorder characterized by dental problems and skeletal abnormalities. This test utilizes Next Generation Sequencing (NGS) technology, which allows for a comprehensive analysis of the ALPL gene to detect subtle genetic variations. Understanding your genetic makeup related to the ALPL gene is important for managing potential health risks and making informed healthcare decisions. This test can provide crucial insights for individuals with symptoms or a family history of related conditions.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo specific fasting is required. Discuss any medications you are taking with your doctor or the laboratory. A genetic counseling session and family history assessment are recommended before the test.

SampleBlood sample (usually collected in an EDTA tube) or saliva sample. Confirm specific requirements with the laboratory before booking.

MethodologyNext Generation Sequencing (NGS) is used to analyze the ALPL gene for specific mutations, including single nucleotide variants, insertions, and deletions.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test primarily analyzes the ALPL gene. It may not detect mutations in other genes that could cause similar symptoms. Results should be interpreted in the context of clinical findings and family history. The test may not identify all possible variants within the ALPL gene.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

Odontohypophosphatasia is a rare inherited metabolic disorder affecting bone and tooth development, often caused by mutations in the ALPL gene.

Individuals with symptoms like dental problems or bone issues, or those with a family history of the condition, should discuss testing with their doctor.

A blood sample or saliva sample is typically required. Home sample collection may be available.

Results are generally available within 3 to 4 weeks, but this can vary. Confirm with the laboratory.

A genetic counselor can help you understand your results and discuss their implications for your health and family.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp